{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:58:23Z","timestamp":1792601903221,"version":"4.5.0"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s13346-025-02016-2","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:34:13Z","timestamp":1763393653000},"page":"439-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dual drug co-encapsulation into liposomes and liposome-derived nanosystems for improved synergistic treatment of skin diseases"],"prefix":"10.1007","volume":"16","author":[{"given":"Sara","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cl\u00e1udia","family":"Paiva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0036-4894","authenticated-orcid":false,"given":"Patr\u00edcia C.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2016_CR1","doi-asserted-by":"publisher","first-page":"19145","DOI":"10.1021\/acsomega.2c08016","volume":"8","author":"N Raina","year":"2023","unstructured":"Raina N, Rani R, Thakur VK, Gupta M. New insights in topical drug delivery for skin disorders: from a Nanotechnological perspective. ACS Omega. 2023;8:19145\u201367. https:\/\/doi.org\/10.1021\/acsomega.2c08016.","journal-title":"ACS Omega"},{"key":"2016_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bjd.19704","volume":"184","author":"C Flohr","year":"2021","unstructured":"Flohr C, Hay R. Putting the burden of skin diseases on the global map. Br J Dermatol. 2021;184:189\u201390. https:\/\/doi.org\/10.1111\/bjd.19704.","journal-title":"Br J Dermatol"},{"key":"2016_CR3","doi-asserted-by":"publisher","first-page":"101578","DOI":"10.1016\/j.bbrep.2023.101578","volume":"36","author":"M Vasam","year":"2023","unstructured":"Vasam M, Korutla S, Bohara RA. Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023;36:101578. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101578.","journal-title":"Biochem Biophys Rep"},{"key":"2016_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/pharmaceutics16030309","volume":"16","author":"N Dragicevic","year":"2024","unstructured":"Dragicevic N, Maibach HI. Liposomes and other nanocarriers for the treatment of acne vulgaris: improved therapeutic efficacy and skin tolerability. Pharmaceutics. 2024;16:309. https:\/\/doi.org\/10.3390\/pharmaceutics16030309.","journal-title":"Pharmaceutics"},{"key":"2016_CR5","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1038\/s41598-020-62715-3","volume":"10","author":"AHS Heng","year":"2020","unstructured":"Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10:5754. https:\/\/doi.org\/10.1038\/s41598-020-62715-3.","journal-title":"Sci Rep"},{"key":"2016_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945\u2013e97333. https:\/\/doi.org\/10.1016\/j.jaad.2015.12.037.","journal-title":"J Am Acad Dermatol"},{"key":"2016_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","volume":"83","author":"S Devjani","year":"2023","unstructured":"Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023;83:701\u201315. https:\/\/doi.org\/10.1007\/s40265-023-01880-x.","journal-title":"Drugs"},{"key":"2016_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2147\/CCID.S385861","volume":"16","author":"M Kaiser","year":"2023","unstructured":"Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ. Treatment of androgenetic alopecia: current guidance and unmet needs. Clin Cosmet Investig Dermatol. 2023;16:1387\u2013406. https:\/\/doi.org\/10.2147\/CCID.S385861.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2016_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdin.2023.07.005","volume":"13","author":"S Ntshingila","year":"2023","unstructured":"Ntshingila S, Oputu O, Arowolo AT, Khumalo NP. Androgenetic alopecia: an update. JAAD Int. 2023;13:150\u20138. https:\/\/doi.org\/10.1016\/j.jdin.2023.07.005.","journal-title":"JAAD Int"},{"key":"2016_CR10","doi-asserted-by":"publisher","unstructured":"Correia M, Lopes J, Lopes D, Melero A, Makvandi P, Veiga F, et al. Nanotechnology-based techniques for hair follicle regeneration. Biomaterials. 2023;302. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122348.","DOI":"10.1016\/j.biomaterials.2023.122348"},{"key":"2016_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","volume":"57","author":"F Lolli","year":"2017","unstructured":"Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, et al. Androgenetic alopecia: a review. Endocrine. 2017;57:9\u201317. https:\/\/doi.org\/10.1007\/s12020-017-1280-y.","journal-title":"Endocrine"},{"key":"2016_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","volume":"23","author":"HJC de Vries","year":"2022","unstructured":"de Vries HJC, Schallig HD, Cutaneous Leishmaniasis. A 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol. 2022;23:823\u201340. https:\/\/doi.org\/10.1007\/s40257-022-00726-8.","journal-title":"Am J Clin Dermatol"},{"key":"2016_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","volume":"11","author":"RK Madusanka","year":"2022","unstructured":"Madusanka RK, Silva H, Karunaweera ND. Treatment of cutaneous leishmaniasis and insights into Species-Specific responses: A narrative review. Infect Dis Ther. 2022;11:695\u2013711. https:\/\/doi.org\/10.1007\/s40121-022-00602-2.","journal-title":"Infect Dis Ther"},{"key":"2016_CR14","doi-asserted-by":"publisher","unstructured":"Bahrami F, Harandi AM, Rafati S. Biomarkers of cutaneous leishmaniasis. Front Cell Infect Microbiol. 2018;8. https:\/\/doi.org\/10.3389\/fcimb.2018.00222.","DOI":"10.3389\/fcimb.2018.00222"},{"key":"2016_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.idc.2018.10.004","volume":"33","author":"NE Aronson","year":"2019","unstructured":"Aronson NE, Joya CA. Cutaneous leishmaniasis. Infect Dis Clin North Am. 2019;33:101\u201317. https:\/\/doi.org\/10.1016\/j.idc.2018.10.004.","journal-title":"Infect Dis Clin North Am"},{"key":"2016_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005067.pub4","author":"J Heras-Mosteiro","year":"2017","unstructured":"Heras-Mosteiro J, Monge-Maillo B, Pinart M, Lopez Pereira P, Garcia-Carrasco E, Campuzano Cuadrado P, et al. Interventions for old world cutaneous leishmaniasis. Cochrane Database Syst Reviews. 2017. https:\/\/doi.org\/10.1002\/14651858.CD005067.pub4.","journal-title":"Cochrane Database Syst Reviews"},{"key":"2016_CR17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20:1475. https:\/\/doi.org\/10.3390\/ijms20061475.","journal-title":"Int J Mol Sci"},{"key":"2016_CR18","doi-asserted-by":"publisher","first-page":"16095","DOI":"10.3390\/ijms242216095","volume":"24","author":"A-M Man","year":"2023","unstructured":"Man A-M, Or\u0103san MS, Hoteiuc O-A, Ol\u0103nescu-Vaida-Voevod M-C, Mocan T. Inflammation and psoriasis: A comprehensive review. Int J Mol Sci. 2023;24:16095. https:\/\/doi.org\/10.3390\/ijms242216095.","journal-title":"Int J Mol Sci"},{"key":"2016_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C, Pathophysiology. Clinical Presentation, and treatment of psoriasis. JAMA. 2020. https:\/\/doi.org\/10.1001\/jama.2020.4006. 323:1945.","journal-title":"JAMA"},{"key":"2016_CR20","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.3390\/ijms22094983","volume":"22","author":"RG Petit","year":"2021","unstructured":"Petit RG, Cano A, Ortiz A, Espina M, Prat J, Mu\u00f1oz M, et al. Psoriasis: from pathogenesis to Pharmacological and Nano-Technological-Based therapeutics. Int J Mol Sci. 2021;22:4983. https:\/\/doi.org\/10.3390\/ijms22094983.","journal-title":"Int J Mol Sci"},{"key":"2016_CR21","unstructured":"Michalek IMaria L, Belinda. John SMalte. Global report on psoriasis. World Health Organization; 2016."},{"key":"2016_CR22","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.3390\/ijms222111574","volume":"22","author":"M Vi\u010di\u0107","year":"2021","unstructured":"Vi\u010di\u0107 M, Ka\u0161telan M, Brajac I, Soto\u0161ek V, Massari LP. Current concepts of psoriasis Immunopathogenesis. Int J Mol Sci. 2021;22:11574. https:\/\/doi.org\/10.3390\/ijms222111574.","journal-title":"Int J Mol Sci"},{"key":"2016_CR23","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN, Psoriasis. Lancet. 2021;397:1301\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6.","journal-title":"Lancet"},{"key":"2016_CR24","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.3390\/ijms241713313","volume":"24","author":"H-J Lee","year":"2023","unstructured":"Lee H-J, Kim M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 2023;24:13313. https:\/\/doi.org\/10.3390\/ijms241713313.","journal-title":"Int J Mol Sci"},{"key":"2016_CR25","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/med.21754","volume":"41","author":"J Chen","year":"2021","unstructured":"Chen J, Li S, Li C. Mechanisms of melanocyte death in vitiligo. Med Res Rev. 2021;41:1138\u201366. https:\/\/doi.org\/10.1002\/med.21754.","journal-title":"Med Res Rev"},{"key":"2016_CR26","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/cells12060936","volume":"12","author":"W-L Chang","year":"2023","unstructured":"Chang W-L, Ko C-H. The role of oxidative stress in vitiligo: an update on its pathogenesis and therapeutic implications. Cells. 2023;12:936. https:\/\/doi.org\/10.3390\/cells12060936.","journal-title":"Cells"},{"key":"2016_CR27","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","volume":"9","author":"J Akl","year":"2024","unstructured":"Akl J, Lee S, Ju HJ, Parisi R, Kim JY, Jeon JJ, et al. Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health. 2024;9:e386\u201396. https:\/\/doi.org\/10.1016\/S2468-2667(24)00026-4.","journal-title":"Lancet Public Health"},{"key":"2016_CR28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29307","author":"RR Joge","year":"2022","unstructured":"Joge RR, Kathane PU, Joshi SH, Vitiligo. Narrative Rev Article Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.29307.","journal-title":"Narrative Rev Article Cureus"},{"key":"2016_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K, Vitiligo. Rev Dermatology. 2020;236:571\u201392. https:\/\/doi.org\/10.1159\/000506103.","journal-title":"Rev Dermatology"},{"key":"2016_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jid.2020.06.004","volume":"141","author":"RA Spritz","year":"2021","unstructured":"Spritz RA, Santorico SA. The genetic basis of vitiligo. J Invest Dermatology. 2021;141:265\u201373. https:\/\/doi.org\/10.1016\/j.jid.2020.06.004.","journal-title":"J Invest Dermatology"},{"key":"2016_CR31","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2147\/IJN.S245326","volume":"15","author":"M-C Sun","year":"2020","unstructured":"Sun M-C, Xu X-L, Lou X-F, Du Y-Z. Recent progress and future directions: the Nano-Drug delivery system for the treatment of vitiligo. Int J Nanomed. 2020;15:3267\u201379. https:\/\/doi.org\/10.2147\/IJN.S245326.","journal-title":"Int J Nanomed"},{"key":"2016_CR32","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/molecules23092392","volume":"23","author":"I Negut","year":"2018","unstructured":"Negut I, Grumezescu V, Grumezescu AM. Treatment strategies for infected wounds. Molecules. 2018;23:2392. https:\/\/doi.org\/10.3390\/molecules23092392.","journal-title":"Molecules"},{"key":"2016_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.addr.2018.12.014","volume":"146","author":"HS Kim","year":"2019","unstructured":"Kim HS, Sun X, Lee J-H, Kim H-W, Fu X, Leong KW. Advanced drug delivery systems and artificial skin grafts for skin wound healing. Adv Drug Deliv Rev. 2019;146:209\u201339. https:\/\/doi.org\/10.1016\/j.addr.2018.12.014.","journal-title":"Adv Drug Deliv Rev"},{"key":"2016_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12951-019-0514-y","volume":"17","author":"W Wang","year":"2019","unstructured":"Wang W, Lu K, Yu C, Huang Q, Du Y-Z. Nano-drug delivery systems in wound treatment and skin regeneration. J Nanobiotechnol. 2019;17:82. https:\/\/doi.org\/10.1186\/s12951-019-0514-y.","journal-title":"J Nanobiotechnol"},{"key":"2016_CR35","doi-asserted-by":"publisher","first-page":"e08938","DOI":"10.1016\/j.heliyon.2022.e08938","volume":"8","author":"EB Souto","year":"2022","unstructured":"Souto EB, Fangueiro JF, Fernandes AR, Cano A, Sanchez-Lopez E, Garcia ML, et al. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon. 2022;8:e08938. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e08938.","journal-title":"Heliyon"},{"key":"2016_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1517\/17425247.2012.686490","volume":"9","author":"M Gupta","year":"2012","unstructured":"Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv. 2012;9:783\u2013804. https:\/\/doi.org\/10.1517\/17425247.2012.686490.","journal-title":"Expert Opin Drug Deliv"},{"key":"2016_CR37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/pharmaceutics15020656","volume":"15","author":"N Akombaetwa","year":"2023","unstructured":"Akombaetwa N, Ilangala AB, Thom L, Memvanga PB, Witika BA, Buya AB. Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications. Pharmaceutics. 2023;15:656. https:\/\/doi.org\/10.3390\/pharmaceutics15020656.","journal-title":"Pharmaceutics"},{"key":"2016_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00403-011-1166-4","volume":"303","author":"MBR Pierre","year":"2011","unstructured":"Pierre MBR. Dos Santos Miranda Costa I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 2011;303:607. https:\/\/doi.org\/10.1007\/s00403-011-1166-4.","journal-title":"Arch Dermatol Res"},{"key":"2016_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/02652048.2024.2376116","volume":"41","author":"H Hameed","year":"2024","unstructured":"Hameed H, Khan MA, Paiva-Santos AC, Faheem S, Khalid A, Majid MS, et al. Liposomes like advanced drug carriers: from fundamentals to pharmaceutical applications. J Microencapsul. 2024;41:456\u201378. https:\/\/doi.org\/10.1080\/02652048.2024.2376116.","journal-title":"J Microencapsul"},{"key":"2016_CR40","doi-asserted-by":"publisher","first-page":"100837","DOI":"10.1016\/j.mtbio.2023.100837","volume":"23","author":"A Moammeri","year":"2023","unstructured":"Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, et al. Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio. 2023;23:100837. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100837.","journal-title":"Mater Today Bio"},{"key":"2016_CR41","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/ph16101424","volume":"16","author":"PC Pires","year":"2023","unstructured":"Pires PC, Paiva-Santos AC, Veiga F. Liposome-Derived nanosystems for the treatment of behavioral and neurodegenerative diseases: the promise of Niosomes, Transfersomes, and ethosomes for increased brain drug bioavailability. Pharmaceuticals. 2023;16:1424. https:\/\/doi.org\/10.3390\/ph16101424.","journal-title":"Pharmaceuticals"},{"key":"2016_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/biomedicines11020435","volume":"11","author":"H Luiz","year":"2023","unstructured":"Luiz H, Oliveira Pinho J, Gaspar MM. Advancing medicine with Lipid-Based Nanosystems - The successful case of liposomes. Biomedicines. 2023;11:435. https:\/\/doi.org\/10.3390\/biomedicines11020435.","journal-title":"Biomedicines"},{"key":"2016_CR43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1039\/D0RA09561C","volume":"11","author":"C Richard","year":"2021","unstructured":"Richard C, Cassel S, Blanzat M. Vesicular systems for dermal and transdermal drug delivery. RSC Adv. 2021;11:442\u201351. https:\/\/doi.org\/10.1039\/D0RA09561C.","journal-title":"RSC Adv"},{"key":"2016_CR44","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"2016_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/21691401.2023.2247036","volume":"51","author":"S Pande","year":"2023","unstructured":"Pande S. Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artif Cells Nanomed Biotechnol. 2023;51:428\u201340. https:\/\/doi.org\/10.1080\/21691401.2023.2247036.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2016_CR46","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/pharmaceutics16091200","volume":"16","author":"M Corte-Real","year":"2024","unstructured":"Corte-Real M, Veiga F, Paiva-Santos AC, Pires PC. Improving skin cancer treatment by dual drug Co-Encapsulation into liposomal Systems - An integrated approach towards anticancer synergism and targeted delivery. Pharmaceutics. 2024;16:1200. https:\/\/doi.org\/10.3390\/pharmaceutics16091200.","journal-title":"Pharmaceutics"},{"key":"2016_CR47","doi-asserted-by":"publisher","unstructured":"Stefanov SR, Andonova VY. Lipid nanoparticulate drug delivery systems: recent advances in the treatment of skin disorders. Pharmaceuticals. 2021;14. https:\/\/doi.org\/10.3390\/ph14111083.","DOI":"10.3390\/ph14111083"},{"key":"2016_CR48","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/pharmaceutics12090855","volume":"12","author":"SAT Opatha","year":"2020","unstructured":"Opatha SAT, Titapiwatanakun V, Chutoprapat R, Transfersomes. A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12:855. https:\/\/doi.org\/10.3390\/pharmaceutics12090855.","journal-title":"Pharmaceutics"},{"key":"2016_CR49","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1039\/D2NA00530A","volume":"5","author":"L Liu","year":"2023","unstructured":"Liu L, Zhao W, Ma Q, Gao Y, Wang W, Zhang X, et al. Functional nano-systems for transdermal drug delivery and skin therapy. Nanoscale Adv. 2023;5:1527\u201358. https:\/\/doi.org\/10.1039\/D2NA00530A.","journal-title":"Nanoscale Adv"},{"key":"2016_CR50","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11095-021-03053-5","volume":"38","author":"AC Paiva-Santos","year":"2021","unstructured":"Paiva-Santos AC, Silva AL, Guerra C, Peixoto D, Pereira-Silva M, Zeinali M, et al. Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res. 2021;38:947\u201370. https:\/\/doi.org\/10.1007\/s11095-021-03053-5.","journal-title":"Pharm Res"},{"key":"2016_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/nano10020341","volume":"10","author":"S Babaie","year":"2020","unstructured":"Babaie S, Bakhshayesh AR, Del, Ha JW, Hamishehkar H, Kim KH. Invasome: A novel nanocarrier for transdermal drug delivery. Nanomaterials. 2020;10:341. https:\/\/doi.org\/10.3390\/nano10020341.","journal-title":"Nanomaterials"},{"key":"2016_CR52","doi-asserted-by":"publisher","first-page":"111748","DOI":"10.1016\/j.colsurfb.2021.111748","volume":"203","author":"M Elmowafy","year":"2021","unstructured":"Elmowafy M. Skin penetration\/permeation success determinants of nanocarriers: pursuit of a perfect formulation. Colloids Surf B Biointerfaces. 2021;203:111748. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111748.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2016_CR53","doi-asserted-by":"publisher","first-page":"106875","DOI":"10.1016\/j.ejps.2024.106875","volume":"201","author":"R Albash","year":"2024","unstructured":"Albash R, Abdelbari MA, Elbesh RM, Khaleel EF, Badi RM, Eldehna WM, et al. Sonophoresis mediated diffusion of caffeine loaded Transcutol\u00ae enriched cerosomes for topical management of cellulite. Eur J Pharm Sci. 2024;201:106875. https:\/\/doi.org\/10.1016\/j.ejps.2024.106875.","journal-title":"Eur J Pharm Sci"},{"key":"2016_CR54","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1208\/s12249-022-02357-y","volume":"23","author":"S Mosallam","year":"2022","unstructured":"Mosallam S, Albash R, Abdelbari MA. Advanced vesicular systems for antifungal drug delivery. AAPS PharmSciTech. 2022;23:206. https:\/\/doi.org\/10.1208\/s12249-022-02357-y.","journal-title":"AAPS PharmSciTech"},{"key":"2016_CR55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102. https:\/\/doi.org\/10.1186\/1556-276X-8-102.","journal-title":"Nanoscale Res Lett"},{"key":"2016_CR56","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","volume":"14","author":"D Lombardo","year":"2022","unstructured":"Lombardo D, Kiselev MA. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics. 2022;14:543. https:\/\/doi.org\/10.3390\/pharmaceutics14030543.","journal-title":"Pharmaceutics"},{"key":"2016_CR57","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/08982104.2019.1668010","volume":"30","author":"C Has","year":"2020","unstructured":"Has C, Sunthar P. A comprehensive review on recent Preparation techniques of liposomes. J Liposome Res. 2020;30:336\u201365. https:\/\/doi.org\/10.1080\/08982104.2019.1668010.","journal-title":"J Liposome Res"},{"key":"2016_CR58","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3390\/molecules28031449","volume":"28","author":"JA Ataide","year":"2023","unstructured":"Ataide JA, Coco JC, dos Santos \u00c9M, Beraldo-Araujo V, Silva JRA, de Castro KC, et al. Co-Encapsulation of drugs for topical Application - A review. Molecules. 2023;28:1449. https:\/\/doi.org\/10.3390\/molecules28031449.","journal-title":"Molecules"},{"key":"2016_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","volume":"9","author":"X Li","year":"2024","unstructured":"Li X, Peng X, Zoulikha M, Boafo GF, Magar KT, Ju Y, et al. Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal Transduct Target Ther. 2024;9:1. https:\/\/doi.org\/10.1038\/s41392-023-01668-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2016_CR60","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2217\/nnm-2018-0002","volume":"13","author":"S Jain","year":"2018","unstructured":"Jain S, Kale DP, Swami R, Katiyar SS. Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy. Nanomedicine. 2018;13:1481\u201393. https:\/\/doi.org\/10.2217\/nnm-2018-0002.","journal-title":"Nanomedicine"},{"key":"2016_CR61","doi-asserted-by":"publisher","first-page":"20023","DOI":"10.1038\/s41598-023-47302-6","volume":"13","author":"P Ghasemiyeh","year":"2023","unstructured":"Ghasemiyeh P, Moradishooli F, Daneshamouz S, Heidari R, Niroumand U, Mohammadi-Samani S. Optimization, characterization, and follicular targeting assessment of tretinoin and bicalutamide loaded niosomes. Sci Rep. 2023;13:20023. https:\/\/doi.org\/10.1038\/s41598-023-47302-6.","journal-title":"Sci Rep"},{"key":"2016_CR62","doi-asserted-by":"publisher","first-page":"123498","DOI":"10.1016\/j.ijpharm.2023.123498","volume":"646","author":"A Yan","year":"2023","unstructured":"Yan A, Ruan R, Zhu X, Qiang W, Guan Y, Yu Q, et al. Co-delivery of Minoxidil and Tocopherol acetate ethosomes to reshape the hair follicular microenvironment and promote hair regeneration in androgenetic alopecia. Int J Pharm. 2023;646:123498. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123498.","journal-title":"Int J Pharm"},{"key":"2016_CR63","doi-asserted-by":"publisher","unstructured":"Anjum A, Shabbir K, Din FU, Shafique S, Zaidi SS, Almari AH, et al. Co-delivery of amphotericin B and pentamidine loaded Niosomal gel for the treatment of cutaneous leishmaniasis. Drug Deliv. 2023;30. https:\/\/doi.org\/10.1080\/10717544.2023.2173335.","DOI":"10.1080\/10717544.2023.2173335"},{"key":"2016_CR64","doi-asserted-by":"publisher","first-page":"120762","DOI":"10.1016\/j.ijpharm.2021.120762","volume":"604","author":"T Guo","year":"2021","unstructured":"Guo T, Lu J, Fan Y, Zhang Y, Yin S, Sha X, et al. TPGS assists the percutaneous administration of Curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis. Int J Pharm. 2021;604:120762. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120762.","journal-title":"Int J Pharm"},{"key":"2016_CR65","doi-asserted-by":"publisher","first-page":"120826","DOI":"10.1016\/j.ijpharm.2021.120826","volume":"605","author":"X Yang","year":"2021","unstructured":"Yang X, Tang Y, Wang M, Wang Y, Wang W, Pang M, et al. Co-delivery of methotrexate and nicotinamide by cerosomes for topical psoriasis treatment with enhanced efficacy. Int J Pharm. 2021;605:120826. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120826.","journal-title":"Int J Pharm"},{"key":"2016_CR66","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1080\/03639045.2021.2001488","volume":"47","author":"K Jenabikordi","year":"2021","unstructured":"Jenabikordi K, Zadeh BSM, Rezaie A. Co-encapsulation of Metformin and ginger into the liposomes: in vitro characterization and in vivo anti-psoriasis evaluation. Drug Dev Ind Pharm. 2021;47:1447\u201358. https:\/\/doi.org\/10.1080\/03639045.2021.2001488.","journal-title":"Drug Dev Ind Pharm"},{"key":"2016_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jphotobiol.2017.07.007","volume":"174","author":"S Doppalapudi","year":"2017","unstructured":"Doppalapudi S, Mahira S, Khan W. Development and in vitro assessment of psoralen and Resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo. J Photochem Photobiol B. 2017;174:44\u201357. https:\/\/doi.org\/10.1016\/j.jphotobiol.2017.07.007.","journal-title":"J Photochem Photobiol B"},{"key":"2016_CR68","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/jsde.12698","volume":"26","author":"S Saxena","year":"2023","unstructured":"Saxena S, Kushwaha P, Shukla B, Ahmad M. Design and characterization of dual-pronged liposome\u2010embedded gel for enhanced dermal delivery. J Surfactants Deterg. 2023;26:867\u201379. https:\/\/doi.org\/10.1002\/jsde.12698.","journal-title":"J Surfactants Deterg"},{"key":"2016_CR69","doi-asserted-by":"publisher","first-page":"213658","DOI":"10.1016\/j.bioadv.2023.213658","volume":"154","author":"M Kiani","year":"2023","unstructured":"Kiani M, Moraffah F, Khonsari F, Kharazian B, Dinarvand R, Shokrgozar M-A, et al. Co-delivery of Simvastatin and microRNA-21 through liposome could accelerates the wound healing process. Biomaterials Adv. 2023;154:213658. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213658.","journal-title":"Biomaterials Adv"},{"key":"2016_CR70","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/exd.14850","volume":"32","author":"S Babaie","year":"2023","unstructured":"Babaie S, Charkhpour M, Kouhsoltani M, Hamishehkar H, Paiva-Santos AC. Nano\u2010invasomes for simultaneous topical delivery of buprenorphine and bupivacaine for dermal analgesia. Exp Dermatol. 2023;32:1459\u201367. https:\/\/doi.org\/10.1111\/exd.14850.","journal-title":"Exp Dermatol"},{"key":"2016_CR71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.colsurfb.2013.09.055","volume":"114","author":"L Tavano","year":"2014","unstructured":"Tavano L, Muzzalupo R, Picci N, de Cindio B. Co-encapsulation of lipophilic antioxidants into Niosomal carriers: percutaneous permeation studies for cosmeceutical applications. Colloids Surf B Biointerfaces. 2014;114:144\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2013.09.055.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2016_CR72","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/09546634.2012.699179","volume":"24","author":"NH Mohd Nor","year":"2013","unstructured":"Mohd Nor NH, Aziz Z. A systematic review of benzoyl peroxide for acne vulgaris. J Dermatological Treat. 2013;24:377\u201386. https:\/\/doi.org\/10.3109\/09546634.2012.699179.","journal-title":"J Dermatological Treat"},{"key":"2016_CR73","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1517\/14656560903277228","volume":"10","author":"M Sagransky","year":"2009","unstructured":"Sagransky M, Yentzer BA, Feldman SR. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009;10:2555\u201362. https:\/\/doi.org\/10.1517\/14656560903277228.","journal-title":"Expert Opin Pharmacother"},{"key":"2016_CR74","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jocd.12031","volume":"12","author":"A Tirado-S\u00e1nchez","year":"2013","unstructured":"Tirado-S\u00e1nchez A, Esp\u00edndola YS, Ponce\u2010Olivera RM, Bonifaz A. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single\u2010center, randomized, double\u2010blinded, placebo\u2010controlled clinical trial on Mexican patients (skin type III \u2013 IV). J Cosmet Dermatol. 2013;12:103\u20137. https:\/\/doi.org\/10.1111\/jocd.12031.","journal-title":"J Cosmet Dermatol"},{"key":"2016_CR75","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/09546630902763164","volume":"20","author":"C Leok Goh","year":"2009","unstructured":"Leok Goh C, Tang MBY, Briantais P, Kaoukhov A, Soto P. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins. J Dermatological Treat. 2009;20:282\u20138. https:\/\/doi.org\/10.1080\/09546630902763164.","journal-title":"J Dermatological Treat"},{"key":"2016_CR76","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.69341","author":"K Sattar","year":"2024","unstructured":"Sattar K, Sakina S, Mumtaz S, Behram F, Akbar A, Jadoon SK, et al. Safety and efficacy of Fixed-Dose combination of adapalene and benzoyl peroxide in acne vulgaris treatment: A systematic review of clinical trials. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.69341.","journal-title":"Cureus"},{"key":"2016_CR77","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1080\/14656566.2021.1939678","volume":"22","author":"VK Emmerich","year":"2021","unstructured":"Emmerich VK, Purvis CG, Feldman SR. An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne. Expert Opin Pharmacother. 2021;22:1661\u20137. https:\/\/doi.org\/10.1080\/14656566.2021.1939678.","journal-title":"Expert Opin Pharmacother"},{"key":"2016_CR78","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2165\/11208170-000000000-00000","volume":"12","author":"GM Keating","year":"2011","unstructured":"Keating GM. Adapalene 0.1%\/Benzoyl peroxide 2.5% gel. Am J Clin Dermatol. 2011;12:407\u201320. https:\/\/doi.org\/10.2165\/11208170-000000000-00000.","journal-title":"Am J Clin Dermatol"},{"key":"2016_CR79","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.colsurfb.2016.07.029","volume":"146","author":"E Kahraman","year":"2016","unstructured":"Kahraman E, \u00ffzhan G, \u00ffzsoy Y, G\u00fcng\u00f6r S. Polymeric micellar nanocarriers of benzoyl peroxide as potential follicular targeting approach for acne treatment. Colloids Surf B Biointerfaces. 2016;146:692\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.07.029.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2016_CR80","doi-asserted-by":"publisher","unstructured":"Panthi VK, Jha SK, Pangeni R, Paudel KR. Formulation and Development of Adapalene Topical Nanohydrogel Using Different Surfactants and Cosurfactants for Antiacne Activity: In Vitro and Ex Vivo Evaluation. J Nanomater. 2022;2022. https:\/\/doi.org\/10.1155\/2022\/6889293","DOI":"10.1155\/2022\/6889293"},{"key":"2016_CR81","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","volume":"20","author":"SS Kolli","year":"2019","unstructured":"Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical retinoids in acne vulgaris: A systematic review. Am J Clin Dermatol. 2019;20:345\u201365. https:\/\/doi.org\/10.1007\/s40257-019-00423-z.","journal-title":"Am J Clin Dermatol"},{"key":"2016_CR82","first-page":"22","volume":"4","author":"N Schmidt","year":"2011","unstructured":"Schmidt N, Gans EH, Tretinoin. A review of its Anti-inflammatory properties in the treatment of acne. J Clin Aesthet Dermatol. 2011;4:22\u20139.","journal-title":"J Clin Aesthet Dermatol"},{"key":"2016_CR83","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/17512433.2021.1917376","volume":"14","author":"E Bagatin","year":"2021","unstructured":"Bagatin E, da Rocha MAD, Freitas THP, Costa CS. Treatment challenges in adult female acne and future directions. Expert Rev Clin Pharmacol. 2021;14:687\u2013701. https:\/\/doi.org\/10.1080\/17512433.2021.1917376.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2016_CR84","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","volume":"33","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Minoxidil: a comprehensive review. J Dermatological Treat. 2022;33:1896\u2013906. https:\/\/doi.org\/10.1080\/09546634.2021.1945527.","journal-title":"J Dermatological Treat"},{"key":"2016_CR85","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/14656566.2024.2314087","volume":"25","author":"AK Gupta","year":"2024","unstructured":"Gupta AK, Talukder M, Shemer A. Efficacy and safety of low-dose oral Minoxidil in the management of androgenetic alopecia. Expert Opin Pharmacother. 2024;25:139\u201347. https:\/\/doi.org\/10.1080\/14656566.2024.2314087.","journal-title":"Expert Opin Pharmacother"},{"key":"2016_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/pharmaceutics12020149","volume":"12","author":"D Berenguer","year":"2020","unstructured":"Berenguer D, Alcover MM, Sessa M, Halbaut L, Guill\u00e9n C, Boix-Monta\u00f1\u00e9s A, et al. Topical amphotericin B semisolid dosage form for cutaneous leishmaniasis: physicochemical Characterization, ex vivo skin permeation and biological activity. Pharmaceutics. 2020;12:149. https:\/\/doi.org\/10.3390\/pharmaceutics12020149.","journal-title":"Pharmaceutics"},{"key":"2016_CR87","doi-asserted-by":"publisher","first-page":"e0012127","DOI":"10.1371\/journal.pntd.0012127","volume":"18","author":"LL Alves","year":"2024","unstructured":"Alves LL, Freire ML, Troian IL, de Morais-Teixeira E. Local amphotericin B therapy for cutaneous leishmaniasis: A systematic review. PLoS Negl Trop Dis. 2024;18:e0012127. https:\/\/doi.org\/10.1371\/journal.pntd.0012127.","journal-title":"PLoS Negl Trop Dis"},{"key":"2016_CR88","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/tropicalmed8090430","volume":"8","author":"G Santos","year":"2023","unstructured":"Santos G, de Sousa A, Aguiar JM, de Torres AHBM, Coelho KCS, Ferreira AJS. Systematic review of treatment failure and clinical relapses in leishmaniasis from a multifactorial perspective: clinical Aspects, factors associated with the parasite and host. Trop Med Infect Dis. 2023;8:430. https:\/\/doi.org\/10.3390\/tropicalmed8090430.","journal-title":"Trop Med Infect Dis"},{"key":"2016_CR89","doi-asserted-by":"publisher","unstructured":"Sharifi-Rad J, Rayess Y, El, Rizk AA, Sadaka C, Zgheib R, Zam W, et al. Turmeric and its major compound Curcumin on health: bioactive effects and safety profiles for Food, Pharmaceutical, biotechnological and medicinal applications. Front Pharmacol. 2020;11. https:\/\/doi.org\/10.3389\/fphar.2020.01021.","DOI":"10.3389\/fphar.2020.01021"},{"key":"2016_CR90","doi-asserted-by":"publisher","first-page":"116034","DOI":"10.1016\/j.biopha.2023.116034","volume":"170","author":"MR Islam","year":"2024","unstructured":"Islam MR, Rauf A, Akash S, Trisha SI, Nasim AH, Akter M, et al. Targeted therapies of Curcumin focus on its therapeutic benefits in cancers and human health: molecular signaling pathway-based approaches and future perspectives. Biomed Pharmacother. 2024;170:116034. https:\/\/doi.org\/10.1016\/j.biopha.2023.116034.","journal-title":"Biomed Pharmacother"},{"key":"2016_CR91","doi-asserted-by":"publisher","first-page":"e0290637","DOI":"10.1371\/journal.pone.0290637","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Q, Sun S, Jiang L. The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice. PLoS ONE. 2023;18:e0290637. https:\/\/doi.org\/10.1371\/journal.pone.0290637.","journal-title":"PLoS ONE"},{"key":"2016_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1980456","volume":"2020","author":"H Chen","year":"2020","unstructured":"Chen H, Liu H, Tang B, Chen Y, Han L, Yu J, et al. The protective effects of 18\u03b2-Glycyrrhetinic acid on Imiquimod-Induced psoriasis in mice via suppression of mTOR\/STAT3 signaling. J Immunol Res. 2020;2020:1\u20139. https:\/\/doi.org\/10.1155\/2020\/1980456.","journal-title":"J Immunol Res"},{"key":"2016_CR93","doi-asserted-by":"publisher","first-page":"e0153740","DOI":"10.1371\/journal.pone.0153740","volume":"11","author":"J West","year":"2016","unstructured":"West J, Ogston S, Foerster J. Safety and efficacy of methotrexate in psoriasis: A Meta-Analysis of published trials. PLoS ONE. 2016;11:e0153740. https:\/\/doi.org\/10.1371\/journal.pone.0153740.","journal-title":"PLoS ONE"},{"key":"2016_CR94","doi-asserted-by":"publisher","first-page":"126573","DOI":"10.1016\/j.molliq.2024.126573","volume":"417","author":"MA Agafonov","year":"2025","unstructured":"Agafonov MA, Terekhova IV. Impact of components of biorelevant media on solubilization of methotrexate and sulfasalazine by pluronic F127. J Mol Liq. 2025;417:126573. https:\/\/doi.org\/10.1016\/j.molliq.2024.126573.","journal-title":"J Mol Liq"},{"key":"2016_CR95","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10020-021-00376-2","volume":"27","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Li J, Zhong H, Xu Y. The mechanism of nicotinamide on reducing acute lung injury by inhibiting MAPK and NF-\u03baB signal pathway. Mol Med. 2021;27:115. https:\/\/doi.org\/10.1186\/s10020-021-00376-2.","journal-title":"Mol Med"},{"key":"2016_CR96","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.2147\/IJN.S108545","volume":"11","author":"Y Xu","year":"2016","unstructured":"Xu Y, Pan W, Qin M, Zhang G, Long Y, Ruan W, et al. Combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery. Int J Nanomed. 2016;11:4037\u201350. https:\/\/doi.org\/10.2147\/IJN.S108545.","journal-title":"Int J Nanomed"},{"key":"2016_CR97","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/jpm11040251","volume":"11","author":"AMA Stanescu","year":"2021","unstructured":"Stanescu AMA, Simionescu AA, Florea M, Diaconu CC. Is Metformin a possible beneficial treatment for psoriasis? A scoping review. J Pers Med. 2021;11:251. https:\/\/doi.org\/10.3390\/jpm11040251.","journal-title":"J Pers Med"},{"key":"2016_CR98","doi-asserted-by":"publisher","unstructured":"Zhang L, Liu X, Huang M, Wang R, Zhu W, Li Y et al. Metformin inhibits HaCaT cell proliferation under hyperlipidemia through reducing reactive oxygen species via FOXO3 activation. Clin Cosmet Investig Dermatol 2022;15:1403\u201313. https:\/\/doi.org\/10.2147\/CCID.S368845","DOI":"10.2147\/CCID.S368845"},{"key":"2016_CR99","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.3390\/molecules27217223","volume":"27","author":"P Ballester","year":"2022","unstructured":"Ballester P, Cerd\u00e1 B, Arcusa R, Marhuenda J, Yamedjeu K, Zafrilla P. Effect of ginger on inflammatory diseases. Molecules. 2022;27:7223. https:\/\/doi.org\/10.3390\/molecules27217223.","journal-title":"Molecules"},{"key":"2016_CR100","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10787-023-01178-0","volume":"31","author":"OY Elkhawaga","year":"2023","unstructured":"Elkhawaga OY, Ellety MM, Mofty SO, Ghanem MS, Mohamed AO. Review of natural compounds for potential psoriasis treatment. Inflammopharmacology. 2023;31:1183\u201398. https:\/\/doi.org\/10.1007\/s10787-023-01178-0.","journal-title":"Inflammopharmacology"},{"key":"2016_CR101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.det.2019.08.002","volume":"38","author":"EG Richard","year":"2020","unstructured":"Richard EG. The science and (Lost) Art of psoralen plus UVA phototherapy. Dermatol Clin. 2020;38:11\u201323. https:\/\/doi.org\/10.1016\/j.det.2019.08.002.","journal-title":"Dermatol Clin"},{"key":"2016_CR102","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamadermatol.2017.0002","volume":"153","author":"JM Bae","year":"2017","unstructured":"Bae JM, Jung HM, Hong BY, Lee JH, Choi WJ, Lee JH, et al. Phototherapy for vitiligo. JAMA Dermatol. 2017;153:666. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0002.","journal-title":"JAMA Dermatol"},{"key":"2016_CR103","doi-asserted-by":"publisher","first-page":"15","DOI":"10.38212\/2224-6614.1151","volume":"29","author":"M-H Lin","year":"2021","unstructured":"Lin M-H, Hung C-F, Sung H-C, Yang S-C, Yu H-P, Fang J-Y. The bioactivities of Resveratrol and its naturally occurring derivatives on skin. J Food Drug Anal. 2021;29:15\u201338. https:\/\/doi.org\/10.38212\/2224-6614.1151.","journal-title":"J Food Drug Anal"},{"key":"2016_CR104","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40291-023-00672-z","volume":"27","author":"A Bia\u0142czyk","year":"2023","unstructured":"Bia\u0142czyk A, We\u0142niak A, Kami\u0144ska B, Czajkowski R. Oxidative stress and potential antioxidant therapies in vitiligo: A narrative review. Mol Diagn Ther. 2023;27:723\u201339. https:\/\/doi.org\/10.1007\/s40291-023-00672-z.","journal-title":"Mol Diagn Ther"},{"key":"2016_CR105","doi-asserted-by":"publisher","unstructured":"Hwang JR, Cartron AM, Khachemoune A. A review of Nigella sativa plant-based therapy in dermatology. Int J Dermatol. 2021;60. https:\/\/doi.org\/10.1111\/ijd.15615.","DOI":"10.1111\/ijd.15615"},{"key":"2016_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7092514","volume":"2017","author":"AM Eid","year":"2017","unstructured":"Eid AM, Elmarzugi NA, Abu Ayyash LM, Sawafta MN, Daana HI. A review on the cosmeceutical and external applications of Nigella sativa. J Trop Med. 2017;2017:1\u20136. https:\/\/doi.org\/10.1155\/2017\/7092514.","journal-title":"J Trop Med"},{"key":"2016_CR107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/13880200903062614","volume":"48","author":"S Intahphuak","year":"2010","unstructured":"Intahphuak S, Khonsung P, Panthong A. Anti-inflammatory, analgesic, and antipyretic activities of Virgin coconut oil. Pharm Biol. 2010;48:151\u20137. https:\/\/doi.org\/10.3109\/13880200903062614.","journal-title":"Pharm Biol"},{"key":"2016_CR108","doi-asserted-by":"publisher","first-page":"44019","DOI":"10.1021\/acsomega.4c04277","volume":"9","author":"S Abdalla","year":"2024","unstructured":"Abdalla S, Aroua MK, Gew LT. A comprehensive review of Plant-Based cosmetic oils (Virgin coconut Oil, Olive Oil, Argan Oil, and Jojoba Oil): chemical and biological properties and their cosmeceutical applications. ACS Omega. 2024;9:44019\u201332. https:\/\/doi.org\/10.1021\/acsomega.4c04277.","journal-title":"ACS Omega"},{"key":"2016_CR109","doi-asserted-by":"publisher","unstructured":"Xie J, Wu W, Zheng L, Lin X, Tai Y, Wang Y, et al. Roles of MicroRNA-21 in skin wound healing: A comprehensive review. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.828627.","DOI":"10.3389\/fphar.2022.828627"},{"key":"2016_CR110","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/wrr.13100","volume":"31","author":"MC Siu","year":"2023","unstructured":"Siu MC, Voisey J, Zang T, Cuttle L. MicroRNAs involved in human skin burns, wound healing and scarring. Wound Repair Regeneration. 2023;31:439\u201353. https:\/\/doi.org\/10.1111\/wrr.13100.","journal-title":"Wound Repair Regeneration"},{"key":"2016_CR111","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.ajpath.2012.08.023","volume":"181","author":"J Asai","year":"2012","unstructured":"Asai J, Takenaka H, Hirakawa S, Sakabe J, Hagura A, Kishimoto S, et al. Topical Simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol. 2012;181:2217\u201324. https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.023.","journal-title":"Am J Pathol"},{"key":"2016_CR112","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1742-481X.2011.00888.x","volume":"9","author":"S Farsaei","year":"2012","unstructured":"Farsaei S, Khalili H, Farboud ES. Potential role of Statins on wound healing: review of the literature. Int Wound J. 2012;9:238\u201347. https:\/\/doi.org\/10.1111\/j.1742-481X.2011.00888.x.","journal-title":"Int Wound J"},{"key":"2016_CR113","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.2147\/JPR.S231948","volume":"12","author":"JV Pergolizzi Jr","year":"2019","unstructured":"Pergolizzi JV Jr, Raffa RB. Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. J Pain Res. 2019;12:3299\u2013317. https:\/\/doi.org\/10.2147\/JPR.S231948.","journal-title":"J Pain Res"},{"key":"2016_CR114","doi-asserted-by":"publisher","unstructured":"Pergolizzi JV Jr, Magnusson P, LeQuang JA, Breve F, Mitchell K, Chopra M et al. Transdermal buprenorphine for acute pain in the clinical setting: A narrative review. J Pain Res 2021;14:871\u20139. https:\/\/doi.org\/10.2147\/JPR.S280572","DOI":"10.2147\/JPR.S280572"},{"key":"2016_CR115","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1213\/ANE.0000000000005406","volume":"132","author":"Z Jin","year":"2021","unstructured":"Jin Z, Ding O, Islam A, Li R, Lin J. Comparison of liposomal bupivacaine and conventional local anesthetic agents in regional anesthesia: A systematic review. Anesth Analg. 2021;132:1626\u201334. https:\/\/doi.org\/10.1213\/ANE.0000000000005406.","journal-title":"Anesth Analg"},{"key":"2016_CR116","doi-asserted-by":"publisher","first-page":"10918","DOI":"10.1038\/s41598-021-90331-2","volume":"11","author":"MS Durst","year":"2021","unstructured":"Durst MS, Arras M, Palme R, Talbot SR, Jirkof P. Lidocaine and bupivacaine as part of multimodal pain management in a C57BL\/6J laparotomy mouse model. Sci Rep. 2021;11:10918. https:\/\/doi.org\/10.1038\/s41598-021-90331-2.","journal-title":"Sci Rep"},{"key":"2016_CR117","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/ics.12728","volume":"43","author":"J Chen","year":"2021","unstructured":"Chen J, Liu Y, Zhao Z, Qiu J. Oxidative stress in the skin: impact and related protection. Int J Cosmet Sci. 2021;43:495\u2013509. https:\/\/doi.org\/10.1111\/ics.12728.","journal-title":"Int J Cosmet Sci"},{"key":"2016_CR118","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1038\/sj.jid.5700340","volume":"126","author":"DR Bickers","year":"2006","unstructured":"Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatology. 2006;126:2565\u201375. https:\/\/doi.org\/10.1038\/sj.jid.5700340.","journal-title":"J Invest Dermatology"},{"key":"2016_CR119","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3390\/antiox12111954","volume":"12","author":"M Marko","year":"2023","unstructured":"Marko M, Pawliczak R. Resveratrol and its derivatives in inflammatory skin Disorders - Atopic dermatitis and psoriasis: A review. Antioxidants. 2023;12:1954. https:\/\/doi.org\/10.3390\/antiox12111954.","journal-title":"Antioxidants"},{"key":"2016_CR120","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00403-017-1740-5","volume":"309","author":"C Alonso","year":"2017","unstructured":"Alonso C, Mart\u00ed M, Barba C, Carrer V, Rubio L, Coderch L. Skin permeation and antioxidant efficacy of topically applied Resveratrol. Arch Dermatol Res. 2017;309:423\u201331. https:\/\/doi.org\/10.1007\/s00403-017-1740-5.","journal-title":"Arch Dermatol Res"},{"key":"2016_CR121","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/ptr.5640","volume":"30","author":"AR Vaughn","year":"2016","unstructured":"Vaughn AR, Branum A, Sivamani RK. Effects of turmeric (Curcuma longa) on skin health: A systematic review of the clinical evidence. Phytother Res. 2016;30:1243\u201364. https:\/\/doi.org\/10.1002\/ptr.5640.","journal-title":"Phytother Res"},{"key":"2016_CR122","doi-asserted-by":"publisher","unstructured":"Mo Z, Yuan J, Guan X, Peng J. Advancements in dermatological applications of curcumin: clinical efficacy and mechanistic insights in the management of skin disorders. Clin Cosmet Investig Dermatol 2024;17:1083\u201392. https:\/\/doi.org\/10.2147\/CCID.S467442","DOI":"10.2147\/CCID.S467442"},{"key":"2016_CR123","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/life14050599","volume":"14","author":"V Dzyhovskyi","year":"2024","unstructured":"Dzyhovskyi V, Romani A, Pula W, Bondi A, Ferrara F, Melloni E, et al. Characterization methods for Nanoparticle \u2013 Skin interactions: an overview. Life. 2024;14:599. https:\/\/doi.org\/10.3390\/life14050599.","journal-title":"Life"},{"key":"2016_CR124","doi-asserted-by":"publisher","first-page":"102414","DOI":"10.1016\/j.nano.2021.102414","volume":"36","author":"N Friedman","year":"2021","unstructured":"Friedman N, Dagan A, Elia J, Merims S, Benny O. Physical properties of gold nanoparticles affect skin penetration via hair follicles. Nanomedicine. 2021;36:102414. https:\/\/doi.org\/10.1016\/j.nano.2021.102414.","journal-title":"Nanomedicine"},{"key":"2016_CR125","doi-asserted-by":"publisher","first-page":"31","DOI":"10.15171\/apb.2016.06","volume":"6","author":"Z Mardhiah Adib","year":"2016","unstructured":"Mardhiah Adib Z, Ghanbarzadeh S, Kouhsoltani M, Yari Khosroshahi A, Hamishehkar H. The effect of particle size on the deposition of solid lipid nanoparticles in different skin layers: A histological study. Adv Pharm Bull. 2016;6:31\u20136. https:\/\/doi.org\/10.15171\/apb.2016.06.","journal-title":"Adv Pharm Bull"},{"key":"2016_CR126","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1208\/s12249-020-01900-z","volume":"22","author":"A Verma","year":"2021","unstructured":"Verma A, Jain A, Tiwari A, Saraf S, Panda PK, Jain SK. Promising antifungal potential of engineered Non-ionic Surfactant-Based vesicles: in vitro and in vivo studies. AAPS PharmSciTech. 2021;22:19. https:\/\/doi.org\/10.1208\/s12249-020-01900-z.","journal-title":"AAPS PharmSciTech"},{"key":"2016_CR127","doi-asserted-by":"publisher","first-page":"21236","DOI":"10.1021\/acsomega.4c10474","volume":"10","author":"FF Moreira","year":"2025","unstructured":"Moreira FF, Ziebarth J, Babinski TP, Mainardes RM. Development and characterization of Zein\/Eudragit composite nanoparticles for insulin intranasal delivery. ACS Omega. 2025;10:21236\u201349. https:\/\/doi.org\/10.1021\/acsomega.4c10474.","journal-title":"ACS Omega"},{"key":"2016_CR128","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57. https:\/\/doi.org\/10.3390\/pharmaceutics10020057.","journal-title":"Pharmaceutics"},{"key":"2016_CR129","doi-asserted-by":"publisher","unstructured":"Clogston JD, Patri AK, Zeta Potential M. 2011. pp. 63\u201370. https:\/\/doi.org\/10.1007\/978-1-60327-198-1_6","DOI":"10.1007\/978-1-60327-198-1_6"},{"key":"2016_CR130","doi-asserted-by":"publisher","first-page":"9835","DOI":"10.1039\/C5AY02014J","volume":"7","author":"A Sikora","year":"2015","unstructured":"Sikora A, Bartczak D, Gei\u00dfler D, Kestens V, Roebben G, Ramaye Y, et al. A systematic comparison of different techniques to determine the zeta potential of silica nanoparticles in biological medium. Anal Methods. 2015;7:9835\u201343. https:\/\/doi.org\/10.1039\/C5AY02014J.","journal-title":"Anal Methods"},{"key":"2016_CR131","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","volume":"14","author":"Z N\u00e9meth","year":"2022","unstructured":"N\u00e9meth Z, Cs\u00f3ka I, Semnani Jazani R, Sipos B, Haspel H, Kozma G, et al. Quality by Design-Driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics. 2022;14:1798. https:\/\/doi.org\/10.3390\/pharmaceutics14091798.","journal-title":"Pharmaceutics"},{"key":"2016_CR132","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/10717544.2020.1856224","volume":"28","author":"J Li","year":"2021","unstructured":"Li J, Wang Z, Zhang H, Gao J, Zheng A. Progress in the development of stabilization strategies for nanocrystal preparations. Drug Deliv. 2021;28:19\u201336. https:\/\/doi.org\/10.1080\/10717544.2020.1856224.","journal-title":"Drug Deliv"},{"key":"2016_CR133","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/pharmaceutics14040778","volume":"14","author":"Y Cao","year":"2022","unstructured":"Cao Y, Dong X, Chen X. Polymer-Modified liposomes for drug delivery: from fundamentals to applications. Pharmaceutics. 2022;14:778. https:\/\/doi.org\/10.3390\/pharmaceutics14040778.","journal-title":"Pharmaceutics"},{"key":"2016_CR134","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1021\/bm700753q","volume":"8","author":"J Thevenot","year":"2007","unstructured":"Thevenot J, Troutier A-L, David L, Delair T, Ladavi\u00e8re C. Steric stabilization of Lipid\/Polymer particle assemblies by Poly(ethylene glycol)-Lipids. Biomacromolecules. 2007;8:3651\u201360. https:\/\/doi.org\/10.1021\/bm700753q.","journal-title":"Biomacromolecules"},{"key":"2016_CR135","doi-asserted-by":"publisher","unstructured":"Giannopoulos-Dimitriou A, Saiti A, Petrou A, Vizirianakis IS, Fatouros DG. Liposome stability and integrity. Liposomes in drug delivery. Elsevier; 2024. pp. 89\u2013121. https:\/\/doi.org\/10.1016\/B978-0-443-15491-1.00022-5.","DOI":"10.1016\/B978-0-443-15491-1.00022-5"},{"key":"2016_CR136","doi-asserted-by":"publisher","unstructured":"Zhang T, Zheng X, Lin R, Sun H, Wu H, Zhang J, et al. Lyophilizable stem Cell-Hybrid liposome with Long\u2010Term stability and high targeting capacity. Adv Healthc Mater. 2024;13. https:\/\/doi.org\/10.1002\/adhm.202400704.","DOI":"10.1002\/adhm.202400704"},{"key":"2016_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.12.012","volume":"537","author":"S Khadke","year":"2018","unstructured":"Khadke S, Stone P, Rozhin A, Kroonen J, Perrie Y. Point of use production of liposomal solubilised products. Int J Pharm. 2018;537:1\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.12.012.","journal-title":"Int J Pharm"},{"key":"2016_CR138","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/1346-8138.14489","volume":"45","author":"E Proksch","year":"2018","unstructured":"Proksch E. pH in nature, humans and skin. J Dermatol. 2018;45:1044\u201352. https:\/\/doi.org\/10.1111\/1346-8138.14489.","journal-title":"J Dermatol"},{"key":"2016_CR139","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000094670","volume":"19","author":"M-H Schmid-Wendtner","year":"2006","unstructured":"Schmid-Wendtner M-H, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19:296\u2013302. https:\/\/doi.org\/10.1159\/000094670.","journal-title":"Skin Pharmacol Physiol"},{"key":"2016_CR140","doi-asserted-by":"publisher","first-page":"107142","DOI":"10.1016\/j.jddst.2025.107142","volume":"111","author":"AA Elaine","year":"2025","unstructured":"Elaine AA, Othman R, Mita SR, Hasanah AN. Breaking boundaries in controlled release drug delivery system: the promise and potential of molecularly imprinted polymers. J Drug Deliv Sci Technol. 2025;111:107142. https:\/\/doi.org\/10.1016\/j.jddst.2025.107142.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2016_CR141","doi-asserted-by":"publisher","first-page":"100209","DOI":"10.1016\/j.nxnano.2025.100209","volume":"8","author":"R Chelliah","year":"2025","unstructured":"Chelliah R, Rubab M, Vijayalakshmi S, Karuvelan M, Barathikannan K, Oh D-H. Liposomes for drug delivery: Classification, therapeutic applications, and limitations. Next Nanatechnol. 2025;8:100209. https:\/\/doi.org\/10.1016\/j.nxnano.2025.100209.","journal-title":"Next Nanatechnol"},{"key":"2016_CR142","doi-asserted-by":"publisher","unstructured":"Abboud HA, Zelk\u00f3 R, Kazsoki A. A systematic review of liposomal nanofibrous scaffolds as a drug delivery system: a decade of progress in controlled release and therapeutic efficacy. Drug Deliv. 2025;32. https:\/\/doi.org\/10.1080\/10717544.2024.2445259.","DOI":"10.1080\/10717544.2024.2445259"},{"key":"2016_CR143","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12951-025-03660-z","volume":"23","author":"A Choudhury","year":"2025","unstructured":"Choudhury A, Kirti A, Lenka SS, Naser SS, Sinha A, Kumari S, et al. Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis. J Nanobiotechnol. 2025;23:576. https:\/\/doi.org\/10.1186\/s12951-025-03660-z.","journal-title":"J Nanobiotechnol"},{"key":"2016_CR144","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jconrel.2023.03.049","volume":"357","author":"C Ni","year":"2023","unstructured":"Ni C, Zhang Z, Wang Y, Zhang Z, Guo X, Lv H. Hyaluronic acid and HA-modified cationic liposomes for promoting skin penetration and retention. J Controlled Release. 2023;357:432\u201343. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.049.","journal-title":"J Controlled Release"},{"key":"2016_CR145","doi-asserted-by":"publisher","first-page":"122290","DOI":"10.1016\/j.ijpharm.2022.122290","volume":"628","author":"X Lv","year":"2022","unstructured":"Lv X, Wu Z, Qi X. High skin permeation, deposition and whitening activity achieved by Xanthan gum string vitamin c flexible liposomes for external application. Int J Pharm. 2022;628:122290. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122290.","journal-title":"Int J Pharm"},{"key":"2016_CR146","doi-asserted-by":"publisher","first-page":"119210","DOI":"10.1016\/j.ijpharm.2020.119210","volume":"580","author":"MG Davan\u00e7o","year":"2020","unstructured":"Davan\u00e7o MG, Campos DR, Carvalho P. De O. In vitro \u2013 In vivo correlation in the development of oral drug formulation: A screenshot of the last two decades. Int J Pharm. 2020;580:119210. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119210.","journal-title":"Int J Pharm"},{"key":"2016_CR147","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jconrel.2015.09.052","volume":"219","author":"J Shen","year":"2015","unstructured":"Shen J, Burgess DJ. In vitro \u2013 in vivo correlation for complex non-oral drug products: where do we stand? J Controlled Release. 2015;219:644\u201351. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.052.","journal-title":"J Controlled Release"},{"key":"2016_CR148","doi-asserted-by":"publisher","first-page":"123942","DOI":"10.1016\/j.ijpharm.2024.123942","volume":"654","author":"K Gan","year":"2024","unstructured":"Gan K, Li Z, Darli PM, Wong T, Modh H, Gottier P, et al. Understanding the in Vitro - in vivo nexus: advanced correlation models predict clinical performance of liposomal doxorubicin. Int J Pharm. 2024;654:123942. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123942.","journal-title":"Int J Pharm"},{"key":"2016_CR149","doi-asserted-by":"publisher","unstructured":"Huang R, Pei L, Liu Q, Chen S, Dou H, Shu G, et al. Isobologram analysis: A comprehensive review of methodology and current research. Front Pharmacol. 2019;10. https:\/\/doi.org\/10.3389\/fphar.2019.01222.","DOI":"10.3389\/fphar.2019.01222"},{"key":"2016_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.106.104117","volume":"319","author":"RJ Tallarida","year":"2006","unstructured":"Tallarida RJ. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther. 2006;319:1\u20137. https:\/\/doi.org\/10.1124\/jpet.106.104117.","journal-title":"J Pharmacol Exp Ther"},{"key":"2016_CR151","doi-asserted-by":"publisher","first-page":"100110","DOI":"10.1016\/j.crphar.2022.100110","volume":"3","author":"D Duarte","year":"2022","unstructured":"Duarte D, Vale N. Evaluation of synergism in drug combinations and reference models for future orientations in oncology. Curr Res Pharmacol Drug Discovery. 2022;3:100110. https:\/\/doi.org\/10.1016\/j.crphar.2022.100110.","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"2016_CR152","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.colsurfa.2015.01.019","volume":"469","author":"E L\u00e9mery","year":"2015","unstructured":"L\u00e9mery E, Brian\u00e7on S, Chevalier Y, Bordes C, Oddos T, Gohier A, et al. Skin toxicity of surfactants: Structure\/toxicity relationships. Colloids Surf Physicochem Eng Asp. 2015;469:166\u201379. https:\/\/doi.org\/10.1016\/j.colsurfa.2015.01.019.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"2016_CR153","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cis.2018.04.002","volume":"256","author":"A Seweryn","year":"2018","unstructured":"Seweryn A. Interactions between surfactants and the skin \u2013 Theory and practice. Adv Colloid Interface Sci. 2018;256:242\u201355. https:\/\/doi.org\/10.1016\/j.cis.2018.04.002.","journal-title":"Adv Colloid Interface Sci"},{"key":"2016_CR154","doi-asserted-by":"publisher","first-page":"32536","DOI":"10.1038\/s41598-025-18487-9","volume":"15","author":"M Celikoglu","year":"2025","unstructured":"Celikoglu M, Raab C, Vollert H, Harder J, Liu X, Baines JF, et al. A pilot study on the cutaneous effects of ethanol in a moisturizing cream on non-lesional skin of patients with atopic dermatitis. Sci Rep. 2025;15:32536. https:\/\/doi.org\/10.1038\/s41598-025-18487-9.","journal-title":"Sci Rep"},{"key":"2016_CR155","doi-asserted-by":"publisher","unstructured":"An SSA, Ryu HJ, Seo M, yeb, Jung SK, Meang E-H, Lee S-Y, et al. Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats. Int J Nanomed. 2014;137. https:\/\/doi.org\/10.2147\/IJN.S57930.","DOI":"10.2147\/IJN.S57930"},{"key":"2016_CR156","doi-asserted-by":"publisher","first-page":"113927","DOI":"10.1016\/j.fct.2023.113927","volume":"178","author":"S Huang","year":"2023","unstructured":"Huang S, Wu Z, Chen Y, Li H, Zou L, Teichmann AT, et al. Dermal repeated dose toxicity study of the anti-breast cancer drug formestane cream in Bama minipig. Food Chem Toxicol. 2023;178:113927. https:\/\/doi.org\/10.1016\/j.fct.2023.113927.","journal-title":"Food Chem Toxicol"},{"key":"2016_CR157","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1111\/j.1524-4725.2007.33358.x","volume":"33","author":"RG Hamilton","year":"2007","unstructured":"Hamilton RG, STROBOS J. Immunogenicity studies of cosmetically administered Nonanimal-Stabilized hyaluronic acid particles. Dermatol Surg. 2007;33:S176\u201385. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.33358.x.","journal-title":"Dermatol Surg"},{"key":"2016_CR158","unstructured":"Zhu D-M, Chen G. US9895313B2 - Combination liposomal pharmaceutical formulations. United States; 2016 [cited 2025 Sep 23]. https:\/\/patents.google.com\/patent\/US9895313B2\/en. Accessed 23 Sep 2025."},{"key":"2016_CR159","unstructured":"Bilgicer ZB, Ashley J, Kiziltepe Bilgicer T. WO2017048990A1 - Dual loaded liposomal nanoparticles. Worldwide applications; 2016 [cited 2025 Sep 23]. https:\/\/patents.google.com\/patent\/WO2017048990A1\/en. Accessed 23 Sep 2025."},{"key":"2016_CR160","unstructured":"Zhu D-M, Chen G. US10736845B2 - Dual loaded liposomal pharmaceutical formulations. United States; 2016 [cited 2025 Sep 23]. https:\/\/patents.google.com\/patent\/US10736845B2\/en. Accessed 23 Sep 2025."},{"key":"2016_CR161","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","volume":"318","author":"DJA Crommelin","year":"2020","unstructured":"Crommelin DJA, van Hoogevest P, Storm G. The role of liposomes in clinical nanomedicine development. What now? Now what? J Controlled Release. 2020;318:256\u201363. https:\/\/doi.org\/10.1016\/j.jconrel.2019.12.023.","journal-title":"J Controlled Release"},{"key":"2016_CR162","doi-asserted-by":"publisher","first-page":"101875","DOI":"10.1016\/j.cocis.2024.101875","volume":"75","author":"R Eugster","year":"2025","unstructured":"Eugster R, Luciani P, Liposomes. Bridging the gap from lab to pharmaceuticals. Curr Opin Colloid Interface Sci. 2025;75:101875. https:\/\/doi.org\/10.1016\/j.cocis.2024.101875.","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"2016_CR163","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics17010036","volume":"17","author":"SS Agrawal","year":"2024","unstructured":"Agrawal SS, Baliga V, Londhe VY. Liposomal formulations: A recent update. Pharmaceutics. 2024;17:36. https:\/\/doi.org\/10.3390\/pharmaceutics17010036.","journal-title":"Pharmaceutics"},{"key":"2016_CR164","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12672-025-01877-w","volume":"16","author":"AO Lawal","year":"2025","unstructured":"Lawal AO, Ogunniyi TJ, Oludele OI, Olorunfemi OA, Okesanya OJ, Ogaya JB, et al. Innovative laboratory techniques shaping cancer diagnosis and treatment in developing countries. Discover Oncol. 2025;16:137. https:\/\/doi.org\/10.1007\/s12672-025-01877-w.","journal-title":"Discover Oncol"},{"key":"2016_CR165","doi-asserted-by":"publisher","first-page":"e0173671","DOI":"10.1371\/journal.pone.0173671","volume":"12","author":"CC Reyes-Aldasoro","year":"2017","unstructured":"Reyes-Aldasoro CC. The proportion of cancer-related entries in pubmed has increased considerably; is cancer truly the emperor of all maladies? PLoS ONE. 2017;12:e0173671. https:\/\/doi.org\/10.1371\/journal.pone.0173671.","journal-title":"PLoS ONE"},{"key":"2016_CR166","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S1470-2045(23)00182-1","volume":"24","author":"SA McIntosh","year":"2023","unstructured":"McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, et al. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments. Lancet Oncol. 2023;24:636\u201345. https:\/\/doi.org\/10.1016\/S1470-2045(23)00182-1.","journal-title":"Lancet Oncol"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02016-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-02016-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-02016-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:41:08Z","timestamp":1768920068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-02016-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":166,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-02016-2","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}